6431 - 6440 of 8801 Results
Title
Year
-
OPENTitle: Lifestyle factors and clinical severity of Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-023-31531-wBest OA location URL: https://www.nature.com/articles/s41598-023-31531-w.pdfCitation Count: 12
- Effect of dopaminergic medications on Montreal Cognitive Assessment in Parkinson's disease patients2025RESTRICTEDTitle: Effect of dopaminergic medications on Montreal Cognitive Assessment in Parkinson's disease patientsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 138Issue #:Start Page: 107951End Page: 107951Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107951Citation Count: 0
-
OPENTitle: Use of Amplified Lewy Body Dementia Fibrils and Autoradiography to Characterize Binding of Radioligand Tg-1-90B to Alpha-Synuclein Fibrils in Postmortem Brain TissueJournal Name: CellsPublisher: MDPI AGVol: 14Issue #: 18Start Page: 1477End Page: 1477Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells14181477Best OA location URL: https://doi.org/10.3390/cells14181477Citation Count: 0
-
RESTRICTEDTitle: Expert comment to: Novel Xp21.1 deletion associated with unusual features in large McLeod syndrome kindredJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 79Issue #:Start Page: 133End Page: 134Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.024Citation Count: 2
-
OPENTitle: Phosphorylation of Parkin at serine 65 is essential for its activationin vivoJournal Name: Open BiologyPublisher: The Royal SocietyVol: 8Issue #: 11Start Page: 180108End Page: 180108Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1098/rsob.180108Best OA location URL: https://pub.dzne.de/search?p=id:%22DZNE-2020-06682%22Citation Count: 111
-
RESTRICTEDTitle: Associations of sleep disorders with cerebrospinal fluid α-synuclein in prodromal and early Parkinson’s diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 269Issue #: 5Start Page: 2469End Page: 2478Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-021-10812-2Citation Count: 24
-
RESTRICTEDTitle: Single-pulse subthalamic deep brain stimulation reduces premotor-motor facilitation in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 66Issue #:Start Page: 224End Page: 227Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.08.003Citation Count: 3
-
OPENTitle: D‐512, a novel dopamine D2/3 receptor agonist, demonstrates greater anti‐Parkinsonian efficacy than ropinirole in Parkinsonian ratsJournal Name: British Journal of PharmacologyPublisher: WileyVol: 174Issue #: 18Start Page: 3058End Page: 3071Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/bph.13937Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5573415Citation Count: 23
-
OPENTitle: Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trialJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 30Issue #: 9Start Page: 2631End Page: 2640Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41591-024-03101-8Best OA location URL: https://www.nature.com/articles/s41591-024-03101-8.pdfCitation Count: 11
- Targeting NAAA counters dopamine neuron loss and symptom progression in mouse models of parkinsonism2022OPENTitle: Targeting NAAA counters dopamine neuron loss and symptom progression in mouse models of parkinsonismJournal Name: Pharmacological ResearchPublisher: Elsevier BVVol: 182Issue #:Start Page: 106338End Page: 106338Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.phrs.2022.106338Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9733952Citation Count: 12